Next Article in Journal
Discovery of RC-752, a Novel Sigma-1 Receptor Antagonist with Antinociceptive Activity: A Promising Tool for Fighting Neuropathic Pain
Next Article in Special Issue
Indol-3-ylglyoxylamide as Privileged Scaffold in Medicinal Chemistry
Previous Article in Journal
Scaling the Andean Shilajit: A Novel Neuroprotective Agent for Alzheimer’s Disease
Previous Article in Special Issue
Rapid and Efficient Access to Novel Bio-Inspired 3-Dimensional Tricyclic SpiroLactams as Privileged Structures via Meyers’ Lactamization
 
 
Article

Article Versions Notes

Pharmaceuticals 2023, 16(7), 961; https://doi.org/10.3390/ph16070961
Action Date Notes Link
article xml file uploaded 5 July 2023 04:02 CEST Original file -
article xml uploaded. 5 July 2023 04:02 CEST Update https://www.mdpi.com/1424-8247/16/7/961/xml
article pdf uploaded. 5 July 2023 04:02 CEST Version of Record https://www.mdpi.com/1424-8247/16/7/961/pdf
article supplementary file uploaded. 5 July 2023 04:02 CEST - https://www.mdpi.com/1424-8247/16/7/961#supplementary
article html file updated 5 July 2023 04:03 CEST Original file -
article html file updated 5 July 2023 04:05 CEST Update -
article html file updated 5 July 2023 04:06 CEST Update -
article html file updated 5 July 2023 04:17 CEST Update -
article html file updated 20 July 2023 20:33 CEST Update https://www.mdpi.com/1424-8247/16/7/961/html
Back to TopTop